Home > Healthcare > Medical Devices > Diagnostic Devices > Electrophysiology Market
The global electrophysiology market size was valued at USD 6.9 billion in 2024 and is estimated to grow at 10.4% CAGR from 2025 to 2034. Electrophysiology is the branch of physiology that studies the electrical properties of biological cells and tissues. It focuses on the generation and propagation of electrical signals within cells, particularly in nerve and muscle cells. This field encompasses various techniques to measure and analyze electrical activity, such as electrocardiography (ECG), electromyography (EMG), and patch-clamp recordings.
The global electrophysiology market is substantially driven by the rising prevalence of atrial fibrillation. For instance, in 2020, as per estimates from the Stroke Foundation, over one million people in the UK suffer from atrial fibrillation. With growing geriatric population in England, 80.5% population in England aged 65 years and above will suffer from AF over the coming years. This rising prevalence underscores the urgent need for advanced electrophysiological treatments and diagnostic technologies, which will likely enhance patient outcomes and drive market growth as healthcare providers seek to address this increasing demand for effective management of atrial fibrillation and related cardiac conditions, among others.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Electrophysiology Market Size in 2024: | USD 6.9 Billion |
Forecast Period: | 2025 – 2034 |
Forecast Period 2025 – 2034 CAGR: | 10.4% |
2025 – 2034 Value Projection: | USD 18.8 Billion |
Historical Data for: | 2021-2024 |
No. of Pages: | 132 |
Tables, Charts & Figures: | 182 |
Segments covered: | Product, Indication, End Use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Furthermore, technological advancements in electrophysiology devices are significantly propelling market growth, alongside a rising preference for electrophysiology catheter ablation procedures. These innovations enhance the efficacy and safety of treatments, leading to increased adoption among healthcare providers and improved outcomes for patients with cardiac conditions.